{"id":"palynziq","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Injection site reactions","drugRate":"","severity":"common","organSystem":""},{"effect":"Arthralgia","drugRate":"","severity":"common","organSystem":""},{"effect":"Hypersensitivity reactions","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Generalized skin reactions lasting at least 14 days","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Abdominal pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Cough","drugRate":"","severity":"common","organSystem":""},{"effect":"Oropharyngeal pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Nasal congestion","drugRate":"","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Anxiety","drugRate":"","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"3%","severity":"serious"},{"effect":"Angioedema","drugRate":"1%","severity":"serious"},{"effect":"Hypersensitivity reactions","drugRate":"6%","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["Pegvaliase"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Palynziq","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:33:40.805798+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:33:57.544157+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:33:46.592015+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Palynziq","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:33:46.919849+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Phenylalanine hydrolytic enzyme","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:33:48.041563+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297802/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:33:47.630674+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"6dba844a-db02-44f8-8593-ce497ed9406c","title":"PALYNZIQ (PEGVALIASE-PQPZ) INJECTION, SOLUTION [BIOMARIN PHARMACEUTICAL INC.]"},"aiSummary":"Palynziq, developed by Emory University, is a marketed drug for the treatment of classical phenylketonuria. Its key strength lies in its unique mechanism of action, which differentiates it in the market. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.","ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T03:13:40.579Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:33:57.544242+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Classical phenylketonuria","diseaseId":"classical-phenylketonuria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05813678","phase":"","title":"A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2022-06-06","conditions":"Phenylketonuria (PKU)","enrollment":450},{"nctId":"NCT05579548","phase":"","title":"A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2022-11-22","conditions":"Phenylketonuria, Maternal","enrollment":50},{"nctId":"NCT06305234","phase":"","title":"A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-01-20","conditions":"Phenylketonuria (PKU)","enrollment":200},{"nctId":"NCT07477691","phase":"PHASE4","title":"Immune Modulation During Palynziq® Treatment in Adults (IMPALA)","status":"NOT_YET_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2026-03-31","conditions":"Phenylketonuria","enrollment":12},{"nctId":"NCT04404530","phase":"","title":"Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)","status":"RECRUITING","sponsor":"Emory University","startDate":"2019-10-08","conditions":"Phenylketonurias","enrollment":45},{"nctId":"NCT05356377","phase":"","title":"Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2022-05-25","conditions":"Phenylketonurias","enrollment":6},{"nctId":"NCT06780332","phase":"PHASE4","title":"Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2025-01","conditions":"Phenylketonuria, PKU","enrollment":10},{"nctId":"NCT03792451","phase":"","title":"Nutrition Status of Adults Treated With Pegvaliase","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2019-01-17","conditions":"Phenylketonurias","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL4297802"},"formularyStatus":[],"_approvalHistory":[{"date":"20201006","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20251120","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20180524","type":"ORIG","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20201120","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20201006","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20201006","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20231209","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"},{"date":"20260227","type":"SUPPL","sponsor":"BIOMARIN PHARM","applicationNumber":"BLA761079"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":24,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Palynziq","genericName":"Palynziq","companyName":"Emory University","companyId":"emory-university","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:33:57.544242+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}